Adma Biologics (ADMA) Other Working Capital Changes (2011 - 2025)
Adma Biologics' (ADMA) quarterly Other Working Capital Changes came in at $547000.0 in Q4 2025, up 136.08% YoY from $231699.4 in Q4 2024, and up 148.97% on a QoQ basis from -$1.1 million in Q3 2025.
Adma Biologics (ADMA) Other Working Capital Changes (2011 - 2025) Analysis & Trends
Adma Biologics (ADMA) has 12 years of Other Working Capital Changes data on file, last reported at $547000.0 in Q4 2025.
- Quarterly Other Working Capital Changes rose 136.08% year-over-year to $547000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (down 43.41% YoY) and the FY2025 annual result came in at $1.5 million, down 43.41% from the prior year.
- Other Working Capital Changes improved to $547000.0 in Q4 2025, from -$1.1 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.0 million in Q3 2024 to a low of -$1.6 million in Q1 2024.
- A 5-year average of $325400.0 and a median of -$64095.0 in 2021 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 3690.18% in 2024, down 767.84% in 2024.
- Tracing ADMA's Other Working Capital Changes over 5 years: stood at -$1.5 million in 2021, then soared by 81.76% to -$277238.0 in 2022, then soared by 181.88% to $227000.0 in 2023, then tumbled by 767.84% to -$1.5 million in 2024, then jumped by 136.08% to $547000.0 in 2025.
- The last three Other Working Capital Changes figures came in at $547000.0 (Q4 2025), -$1.1 million (Q3 2025), and -$501000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 547,000.00 |
| Dec 31, 2025 | 547,000.00 |
| Dec 31, 2025 | 547,000.00 |
| Sep 30, 2025 | -1.12 Mn |
| Sep 30, 2025 | -1.12 Mn |
| Sep 30, 2025 | -1.12 Mn |
| Jun 30, 2025 | -501,000.00 |
| Jun 30, 2025 | -501,000.00 |
| Jun 30, 2025 | -501,000.00 |
| Mar 31, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.78 Mn |